PHG vs MDT Comparison: AI Score, Valuation, Performance and Upside
Compare Philips and Medtronic by imaging and patient monitoring vs cardiac rhythm management, recall resolution progress, software-enabled device strategy, international exposure, and long-term innovation pipeline.
Use this Philips vs Medtronic comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.
PHG holds the edge across 3 of 5 key metrics in this comparison. PHG leads on both 1-year return (+5.22%) and forward P/E quality (12.94x vs 12.99x for MDT), a relatively favorable combination of momentum and valuation. Analyst consensus implies meaningfully more upside for PHG (+27.09%) than for MDT (+17.60%).
| Metric | PHG | MDT |
|---|---|---|
| AI score | 40.6 | 40.6 |
| AI rank | #1103 | #1102 |
| Latest close | $26.17 | $83.21 |
| 1M return | -2.10% | +3.84% |
| 6M return | -8.58% | -17.52% |
| 1Y return | +5.22% | -9.87% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | PHG | MDT |
|---|---|---|
| 1Y ago | $10.94K (+9.4%) started 2025-07-24 | $8.95K (-10.5%) started 2025-07-25 |
| 5Y ago | $7.22K (-27.8%) started 2021-07-26 | $8.25K (-17.5%) started 2021-07-26 |
| 10Y ago | $15.17K (+51.7%) started 2016-07-25 | $15.26K (+52.6%) started 2016-07-25 |
Hypothetical — past performance does not guarantee future results.
| Metric | PHG | MDT |
|---|---|---|
| Market cap | $25.44B | $106.5B |
| Trailing P/E | 22.96 | 22.31 |
| Forward P/E | 12.94 | 12.99 |
| Price/Sales | 1.44 | N/A |
| EV/Revenue | 1.73 | 3.49 |
| Analyst target | $33.26 | $97.84 |
| Target upside | +27.09% | +17.60% |
| Metric | PHG | MDT |
|---|---|---|
| Revenue growth | -4.70% | 9.90% |
| Earnings growth | 97.20% | 18.30% |
| EPS growth | +97.20% | +18.30% |
| FCF margin | +8.61% | +12.72% |
| Operating margin | N/A | 22.05% |
| Profit margin | 5.50% | 13.20% |
| ROIC proxy | 8.36% | 9.84% |
| Return on equity | 8.36% | 9.84% |
| Dividend yield | 3.89% | 3.46% |
| Beta | 0.92 | 0.58 |
| Debt/equity | 70.91 | 58.21 |
| Current ratio | 1.32 | 2.13 |
| Quick ratio | 0.79 | 1.36 |
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | PHG | MDT |
|---|---|---|---|
| 1Y | Growth | +5.22% | -10.47% |
| CAGR | +5.23% | -10.50% | |
| Sharpe ratio | 0.17 | -0.56 | |
| Max drawdown | 22.27% | 30.00% | |
| Max daily drop | 5.68% | 5.11% | |
| Max wkly drop | 9.59% | 7.05% | |
| 5Y | Growth | -36.17% | -27.01% |
| CAGR | -8.60% | -6.11% | |
| Sharpe ratio | -0.17 | -0.37 | |
| Max drawdown | 74.80% | 45.10% | |
| Max daily drop | 15.95% | 7.26% | |
| Max wkly drop | 18.61% | 11.81% | |
| 10Y | Growth | +20.90% | +19.39% |
| CAGR | +1.92% | +1.79% | |
| Sharpe ratio | 0.08 | 0.00 | |
| Max drawdown | 79.61% | 45.10% | |
| Max daily drop | 15.95% | 12.82% | |
| Max wkly drop | 19.10% | 19.36% |
| Category | PHG | MDT |
|---|---|---|
| Company | PHG | MDT |
| Sector | N/A | Healthcare |
| Industry | N/A | N/A |
| Core business | N/A | N/A |
| Investor focus | N/A | N/A |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.